ResMed Capital Expenditure Trend

ResMed Inc -- USA Stock  

USD 98.18  1.70  1.76%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Capital Expenditure of ResMed Inc with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived, physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.
Capital Expenditure  10 Years Trend  
 Capital Expenditure 

ResMed Capital Expenditure Over Time

2016-12-31 (58,534,000) 
2017-12-31 (58,534,000) 
2018-12-31 (68,863,529) 

Other Fundumenentals


Regression Statistics

Arithmetic Mean (61,563,348)
Coefficient Of Variation (29.24)
Mean Deviation  11,203,760
Median (58,534,000)
Standard Deviation  18,002,592
Range  80,470,000
R Value (0.13)
R Squared  0.017278
Significance  0.67
Slope (607,622)

Currently Trending

Sold over 70 shares of
2 days ago ago
Traded for 37.94
Purchased over 40 shares of
2 days ago ago
Traded for 61.5945
Sold over 200 shares of
2 days ago ago
Traded for 11.15